Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 70

Huohua Siwei heads for US IPO

The Chinese online tuition provider which counts Tencent, Longfor Properties, Yuanfudao and Kuaishou as investors, has filed to raise $100m in a US offering.

Jun 23, 2021

Couchbase logs IPO filing

NTT Docomo is set to exit the database technology provider in a flotation on the Nasdaq Global Select Market that will follow some $250m of venture funding.

Jun 23, 2021

Quanergy constructs $1.4bn reverse merger

Samsung, Delphi and Sensata-backed lidar technology developer will get a New York Stock Exchange listing through the deal, conducted at a $1.4bn valuation.

Jun 23, 2021

Daily Deal Round Up: June 22, 2021

Maersk Growth and Raed Ventures co-led a $42m round for shipping platform developer Trella while GV exited deep learning software provider Determined AI.

Jun 22, 2021

Blend Labs looks to join public markets

Salesforce-backed lending software producer Blend has raised more than $685m in funding and hit a $3.3bn valuation in its last funding round five months ago.

Jun 22, 2021

Century Therapeutics runs to $211m IPO

Bayer and Fujifilm scored exits as the cancer treatment developer floated on the Nasdaq Global Select Market at the top of its range.

Jun 22, 2021

JP Morgan Chase nabs Nutmeg for $980m

Fubon Financial Holdings, Goldman Sachs and Schroders are set to exit Nutmeg, which will boost JP Morgan Chase's digital wealth management business.

Jun 21, 2021

Cyteir captures $133m in initial public offering

The cancer therapy developer and Jackson Laboratory spinout floated at the upper end of its range and now has a $600m market cap.

Jun 21, 2021

Cyteir captures $133m in initial public offering

Novo and Celgene will retain shares in the cancer therapy developer, which floated at the upper end of its range and which now has a $600m market cap.

Jun 21, 2021

Ambrx accesses $126m through IPO

The antibody-based drug developer, which counts WuXi AppTec, Fosun, Sinopharm and Humanwell as investors, has floated in a $126m offering.

Jun 21, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here